INTRODUCTION: The aim of this study was to determine the effect of hNT neuron transplants on motor neuron function in SOD1 (G93A) mice when motor deficits were already apparent. METHOD: The hNT neurons were implanted into L(4)-L(5) segments of the ventral horn spinal cord of mice at 15-16 weeks of age: either G93A mice, transgenic mice carrying the normal allele for human SOD1 gene (hTg), or control wild type mice (wt). Behavioral tests (rotorod, beam balance, extension reflex, footprint) were performed prior to transplantation and at weekly intervals afterwards. RESULTS: HNT neuron transplantation in the SOD1 mice delayed disease progression for 3-4 weeks, although lifespan was not affected. CONCLUSION: These results suggest that hNT neuron transplantation may be a promising therapeutic strategy for ALS in the later phase of the neurodegeneration.
INTRODUCTION: The aim of this study was to determine the effect of hNT neuron transplants on motor neuron function in SOD1 (G93A) mice when motor deficits were already apparent. METHOD: The hNT neurons were implanted into L(4)-L(5) segments of the ventral horn spinal cord of mice at 15-16 weeks of age: either G93Amice, transgenic mice carrying the normal allele for humanSOD1 gene (hTg), or control wild type mice (wt). Behavioral tests (rotorod, beam balance, extension reflex, footprint) were performed prior to transplantation and at weekly intervals afterwards. RESULTS:HNT neuron transplantation in the SOD1mice delayed disease progression for 3-4 weeks, although lifespan was not affected. CONCLUSION: These results suggest that hNT neuron transplantation may be a promising therapeutic strategy for ALS in the later phase of the neurodegeneration.
Authors: Svitlana Garbuzova-Davis; Samuel Saporta; Edward Haller; Irina Kolomey; Steven P Bennett; Huntington Potter; Paul R Sanberg Journal: PLoS One Date: 2007-11-21 Impact factor: 3.240
Authors: Angelo C Lepore; Britta Rauck; Christine Dejea; Andrea C Pardo; Mahendra S Rao; Jeffrey D Rothstein; Nicholas J Maragakis Journal: Nat Neurosci Date: 2008-10-19 Impact factor: 24.884
Authors: Svitlana Garbuzova-Davis; Cyndy Davis Sanberg; Nicole Kuzmin-Nichols; Alison E Willing; Carmelina Gemma; Paula C Bickford; Christina Miller; Robert Rossi; Paul R Sanberg Journal: PLoS One Date: 2008-06-25 Impact factor: 3.240